Pfizer (PFE)

R&D Expenses

$12.79B

TTM · Period ending: · USD

PFE logo

PFE R&D Expenses

Latest reported$12.79B
PFE TTM R&D Expenses ($0.00 → $12.79B)
High-resolution chart · PNG

PFE r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
4,432,000,000
4,402,000,000
4,086,000,000
3,583,000,000
3,252,000,000
2,833,000,000
2,776,000,000
2,714,000,000
2,570,000,000
2,477,000,000
2,327,000,000
2,206,000,000
2,133,000,000
2,020,000,000
2,060,000,000
1,483,000,000
1,557,000,000
1,096,000,000
551,000,000
551,000,000
481,000,000
955,000,000
1,382,000,000
1,382,000,000
1,318,000,000
1,201,000,000
1,127,000,000
1,127,000,000
710,000,000
353,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.